|
In this issue:
|
|

|
The new Framingham risk score AND beyond
Approaches to SHAPE the Future of Preventive Cardiology
Dr Valentin Fuster presents the SHAPE Award to Dr Dan Levy, Director of Framingham Heart Study and Dr Kwame Akosah, Professor of Internal Medicine at Univ of Virginia.
|
|
Program
features the evolution of Framingham Risk Scoring and proposed
multimodality approaches for CVD risk assessment. Moderators: Drs Blumenthal, Naghavi and Shah. Register now, space is limited. Online CME available
|
q March's new slides in the PowerPoint Library
 |
Predictive Value of Coronary Calcifications for Future Cardiac Events in Asymptomatic Individuals
Presented by:
Alexander Becker, MD, Alexander Leber, Christoph Becker, MD, Andreas Knez, MD
|
 |
Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gating
Presented by:
Husmann L., Valenta I., Gaemperli O., Adda O., Treyer V., Wyss CA, Veit-Haibach P., Tatsugami F., von Schulthess GK, Kaufmann PA
|
 |
Genome-wide Admixture Mapping for Coronary Artery Calcification in African Americans: The NHLBI Family Heart Study
Presented by:
Qunyuan
Zhang, Cora E. Lewis, Lynne E. Wagenknecht, Richard H. Myers, James S.
Pankow, Steven C. Hunt, Kari E. North, James E. Hixson, J. Jeffrey
Carr, Lawrence C. Shimmin, Ingrid Borecki, Michael A. Province
|
 |
Early treatment reduce the cardiovascular risk in newly diagnosed rheumatoid arthritis patients
Presented by:
AN Georgiadis, PV Voulgari, MI Argyropoulou, Y Alamanos, M Elisaf, AD Tselepis, AA Drosos
|
 |
Difference in Carotid Intima-Media Thickness in Korean and Japanese men
Presented by:
J.
Choo, H. Ueshima, Y. Jang, K. Sutton-Tyrrell, A. El-Saed, T. Kadowaki,
T. Takamiya, T. Okamura, Y. Ueno, Y. Nakamura, A. Sekikawa, J. D. Curb,
L.H. Kuller, & C. Shin
|
 |
Prevalence and Clinical Predictors of Atherosclerotic CAD in Asymptomatic Patients Undergoing Coronary MDCT
Presented by:
Gil N. Bachar, MD, Ran Kornowski, MD, FACC,, MD, Shmuel Fuchs, MD, Eli Atar, MD
|
 |
FDG-PET is an effective imaging modality to detect and quantify age-related atherosclerosis in large arteries
Presented by:
Bural G, Torigian DA, Chamroonrat W, Houseni M,Chen W, Basu S, Kumar R, Alavi A.
|
 |
Automatic Plaque Characterization Employing Quantitative and Multi-contrast MRI
Presented by:
Binjian Sun, Don P. Giddens, Robert Long Jr., W. Robert Taylor, Diana Weiss, Giji Joseph, David Vega, John N. Oshinski
|
 |
Feasibility of low-dose coronary CT angiography: first experience with prospective ECG-gating
Presented by:
Husmann L., Valenta I., Gaemperli O., Adda O., Treyer V., Wyss CA, Veit-Haibach P., Tatsugami F., von Schulthess GK, Kaufmann PA
|
 |
Association
between Cardiovascular Risk Profiles and the Presence and Extent of
Different Types of Coronary Atherosclerotic Plaque as Detected by
Multi-detector Computed Tomography
Presented by:
F.
Bamberg, N. Dannemann, M. D. Shapiro, S. Seneviratne, M. Ferencik, J.
Butler, W. Koenig, K. Nasir, R. C.Cury, A. Tawakol, S. Achenbach, T.J.
Brady, and U. Hoffmann
|
 |
Sex differences in the relation of HDL cholesterol to progression of carotid intima-media thickness: The Los Angeles Atherosclerosis Study
Presented by:
Amy Z. Fan, James H. Dwyer
|
 |
A
Negative Correlation between Human Carotid Atherosclerotic Plaque
Progression and Plaque Wall Stress: In Vivo MRI-Based 2D/3D FSI Models
Presented by:
Dalin Tang, Chun Yang, Sayan Mondal, Fei Liu, Gador Canton, Thomas S. Hatsukami, Chun Yuan
|
 |
Turbulent
blow flow plays an essential localizing role in the development of
atherosclerotic lesions in experimentally-induced Hypercholesterolemia
in rats
Presented by:
Prado CM, Ramos SG, Elias J Jr, Rossi MA
|

|
|
Chairman
Morteza Naghavi, M.D
|
|
Board of Directors
Arthur Agatston, M.D.
Daniel Berman, M.D.
Matthew Budoff, M.D.
Erling Falk, MD, Ph.D.
Craig Hartley, Ph.D.
Harvey Hecht, M.D.
Roxana Mehran, M.D.
Ralph Metcalfe, Ph.D.
Joycelyn Ray, JD.
P.K. Shah, M.D.
Leslee Shaw, Ph.D.
JoAnne Zawitoski, Esq.
Board of Advisors
Juhani Airaksinen, M.D.
Dan E. Arking, M.D.
Juan Badimon, Ph.D
Roger Blumenthal, M.D.
Max A. Cameau, C.A.P.
Jay N. Cohn, M.D.
Ioannis Kakadiaris, Ph.D.
Sanjay Kaul, M.D.
Dan Keeney, A.P.R.
Wolfgang Koenig, MD, Ph.D.
Daniel Lane, MD, Ph.D.
Tasneem Z. Naqvi, M.D.
Director of Scientific Publications
Khurram Nasir, M.D.
Director of Public Relations
Paul Galloway
Director of Fundraising
Barbara S. Loggins
Mission:
To eradicate heart attack by championing new strategies for prevention while advancing the scientific quest for a cure.
|
|
|
|